...
首页> 外文期刊>Iranian Journal of Basic Medical Sciences >Left ventricular phosphorylation patterns of Akt and ERK1/2 after triiodothyronine intracoronary perfusion in isolated hearts and short-term in vivo treatment in Wistar rats
【24h】

Left ventricular phosphorylation patterns of Akt and ERK1/2 after triiodothyronine intracoronary perfusion in isolated hearts and short-term in vivo treatment in Wistar rats

机译:AKT和ERK1 / 2的左心室磷酸化图案在孤立的心脏颅内灌注之后的Thriodothyronine灌注和Wistar大鼠体内体内治疗中的短期

获取原文

摘要

Objective(s): To determine the effects of triiodothyronine (T3) intracoronary perfusion in isolated hearts and short-term administration in rats on the left ventricular (LV) phosphorylation patterns of Akt and ERK1/2. Materials and Methods: Cardiodynamic and hemodynamic parameters were evaluated in Langendorff–perfused hearts. Left ventricles were used for histomorphometric and Western blot analyses. Short-term hyperthyroidism was established by T3 (500 μg.kgsup-1/sup.dsup-1/sup; subcutaneous injection) for 1 (T3sub1d/sub), 3 (T3sub3d/sub), and 10 (T3sub10d/sub) days. Results: Isolated hearts receiving T3 perfusion did not modify LV developed pressure, +dP/dtsubmax/sub, -dP/dtsubmin/sub, heart rate, and coronary perfusion pressure compared with vehicle-perfused hearts. P-ERK1/2 and p-Akt levels in LV tissues after 5, 15, or 60 min of T3 or vehicle perfusion were similar. Compared with their time-matched controls, isolated hearts of T3sub3d/sub and T3sub10d/sub rats exhibited LV hypertrophy and increased absolute values of +dP/dtsubmax/sub and -dP/dtsubmin/sub (i.e., positive inotropic and lusitropic effects). P-ERK1/2 decreased in LV tissues of T3sub1d/sub and T3sub10d/sub but not in those of T3sub3d/sub rats, and p-Akt levels augmented in left ventricles of T3sub3d/sub and stayed unaltered in those of T3sub1d/sub and T3sub10d/sub rats. Conclusion: T3 intracoronary perfusion did not alter cardiodynamics and hemodynamics nor influence the activation of Akt and ERK of normal hearts. Accordingly, the rapid non-genomic effects of T3 were not evident. Short-term T3 treatment provoked cardiac hypertrophy coincidental with increased LV function and associated with transient Akt activation and cyclic ERK1/2 inhibition; which implies activation of physiological hypertrophy signaling and deactivation of pathological hypertrophy signaling, respectively.
机译:目的:确定在左心室(LV)磷酸化模式的左心室(LV)磷酸化图案中分离出心脏和短期施用中三碘噻onγ(T3)骨髓内灌注的影响。AKT和ERK1 / 2。材料和方法:在Langendorff-灌注的心中评估了心动力学和血液动力学参数。左心室用于组织素质和Western印迹分析。 T3(500μg.kg -1 / sup> .d -1 ;皮下注射)的短期甲状腺功能亢进率为1(t3 1d ) ,3(t3 3d )和10(t3 10d )天。结果:孤立的心接收T3灌注没有修改LV显影压力,+ DP / DT Max ,-DP / DT Min ,心率和冠状动物灌注压力与车辆相比 - 熟心的心。在T3或载体灌注的5,15或60分钟后LV组织中的P-ERK1 / 2和P-AKT水平相似。与其时间匹配的对照相比,T3 3D 和T3 10d 大鼠的孤立的心脏表现出LV肥大和增加的绝对值+ dp / dt max 和-dp / dt min (即正透镜和血管效应)。 P-ERK1 / 2在T3 1d 和T3 10d 的LV组织中减少,但不在T3 3d 大鼠的那些中,以及p-akt水平在T3 3d 的左心室中增强,并在T3 1d 和t3 10d 大鼠中保持不变。结论:T3颅内灌注没有改变心脏动力学和血液动力学,也不会影响AKT和ERK的正常心脏的激活。因此,T3的快速非基因组效应并不明显。短期T3治疗引发了心脏肥大巧合,随着LV函数的增加,与瞬时AKT激活和循环ERK1 / 2抑制相关;这意味着分别激活生理肥大信号和病理肥大信号的失活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号